Linzess
Payments companies reported to CMS as associated with Linzess. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Linzess, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Linzess
These are the largest totals companies reported as associated with Linzess. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Darren Brenner | Chicago, IL | Gastroenterology (Internal Medicine) | $79,947.61 |
| John Poulos | Fayetteville, NC | Gastroenterology (Internal Medicine) | $67,900.83 |
| Tung Tran | Denison, TX | Gastroenterology (Internal Medicine) | $49,761.14 |
| Anahita Anderson | Jackson, TN | Family | $47,670.60 |
| Kavita Kongara | Atlanta, GA | Gastroenterology (Internal Medicine) | $41,818.64 |
| Kimberly Orleck | Atlanta, GA | Medical | $41,817.88 |
| Shelley Maillho | Slidell, LA | Family | $34,023.63 |
| Bradley Anderson | Columbia, MO | Gastroenterology (Internal Medicine) | $31,452.17 |
| Preeti Jhawar | Westlake, OH | Gastroenterology (Internal Medicine) | $28,501.69 |
| Pradnya Mitroo | Fresno, CA | Gastroenterology (Internal Medicine) | $27,796.59 |
Prescribed Linzess?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.